⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KLRA News
Kailera Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
KLRA
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
KLRA
Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
globenewswire.com
KLRA
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
globenewswire.com
KLRA
Form 8-K
sec.gov
KLRA
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
globenewswire.com
KLRA
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
prnewswire.com
KLRA
Form 8-K
sec.gov
KLRA
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
globenewswire.com
KLRA